At the end of 2017, the state of Michigan signed into law a multi-bill package to combat the ongoing opioid epidemic.

  • Public Act 250 of 2017

    Effective March 27, 2018

    A professional treating a patient for an opioid-related overdose must provide that patient with information on Substance Use Disorder (SUD) treatment services.

  • Public Act 246 of 2017

    Effective June 1, 2018

    Prior to issuing a control substance prescription, a prescriber must educate the patient and have an attestation form signed.

  • Public Act 248 of 2017

    Effective June 1, 2018

    Prior to prescribing or dispensing a controlled substance prescription exceeding a 3-day supply, the prescriber must obtain and review a MAPS report.

  • Public Act 251 of 2017

    Effective July 1, 2018

    Acute pain opioid prescriptions are limited to 7-day period and supply.
    Pharmacists may partially fill a controlled substance (Schedule 2) prescription

  • Public Act 247 of 2017

    Effective January 4, 2019

    Prescribers must have a bona fide prescriber-patient relationship to prescribe a controlled substance.

For more information about the Michigan Opioid Laws and their implementation, please visit the Frequently Asked Questions sheet, put together by the Department of Licensing and Regulatory Affairs (LARA) and the Michigan Department of Health and Human Services (DHHS).

Download the Michigan Opioid Laws poster

This poster, placed in your waiting or exam rooms, helps patients understand the requirements and limitations, mandated by Michigan law, when writing for prescription opioids.

*Only available for organizations in Michigan

Prescription Drug Monitoring Program (PDMP) and how to interpret a Michigan Automated Prescription System (MAPS) report

Michigan Department of Licensing and Regulatory Affairs (LARA)

Information & Resources